23:32 , Oct 13, 2017 |  BC Extra  |  Company News

Management tracks: Verastem, OxThera

Cancer company Verastem Inc. (NASDAQ:VSTM) named NgocDiep Le CMO. She was VP of immuno-oncology innovative medicines at the MedImmune LLC subsidiary of AstraZeneca plc (LSE:AZN; NYSE:AZN). Rare disease company OxThera AB (Stockholm, Sweden) named Bastian...
22:30 , Apr 14, 2017 |  BioCentury  |  Emerging Company Profile

Tolerating DHODH

Immunic AG is betting on the tolerability and efficacy of its oral, next-generation dihydroorotate dehydrogenase inhibitor to differentiate it from first-generation agents and give it an edge over other types of oral therapies in the...
07:00 , Oct 31, 2016 |  BC Extra  |  Company News

Management tracks

Rainer Boehm is retiring as chief commercial and medical affairs officer at the Novartis Pharma AG division of Novartis AG (NYSE:NVS; SIX:NOVN). Dhaval Patel is also retiring as European head of Novartis Institutes for BioMedical...
07:00 , Sep 12, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Cell adhesion associated oncogene regulated (CDON; CDO); sonic hedgehog homolog (SHH) Mouse studies suggest inhibition of CDON could help treat...
08:00 , Jan 5, 2009 |  BC Week In Review  |  Company News

Targanta infectious news

Targanta will restructure and reduce headcount by 86 (75%) to 27 to conserve capital and focus on regulatory approval of oritavancin in the EU and the U.S. to treat complicated skin and skin structure infections...
07:00 , Aug 18, 2008 |  BC Week In Review  |  Company News

Topigen management update

Topigen Pharmaceuticals Inc. , Montreal, Quebec   Business: Autoimmune, Inflammation   Promoted: Mark Parry-Billings to CEO from CDO; and Lisa Nolan to CBO from SVP of business development; Parry-Billings replaces Paul Wotton, who left earlier...
07:00 , Jul 21, 2008 |  BC Week In Review  |  Company News

Meldex deal

Meldex CDO Steve Martin requested permission from the board to explore his possible acquisition of the company. In response, the board formed an independent committee to consider possible acquisition offers. Further details were not disclosed....
08:00 , Jan 15, 2007 |  BC Week In Review  |  Company News

Movetis management update

Movetis N.V. , Vosselaar, Belgium   Business: Gastrointestinal   Hired: Dirk Reyn as CEO, formerly VP of new business development for Johnson & Johnson 's Janssen-Cilag N.V. unit; Remi Van den Broeck as CDO, formerly...
08:00 , Nov 20, 2006 |  BioCentury  |  Strategy

Playing the India card

Merieux Alliance Group says its acquisition of Shantha Biotechnics Ltd. is intended to provide the French company with a new foothold in Asia. Initially, Merieux says it will simply use its managerial skills to expand...
00:25 , Apr 5, 2006 |  BC Extra  |  Company News

Ace names Darsley CDO

Infectious company Ace (Odense, Denmark) hired Michael Darsley as chief development officer. He was formerly director of vaccine development for Cambridge Biostability ( Cambridge , U.K.)....